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Balancing Dairy Cow Health and Performance: 
Dietary Fat Supplementation and the Role of Ceramide
By Joseph W. McFadden
Fat supplementation of dairy cattle 
diets is a common practice to increase 
dietary energy and to thereby enhance 
milk and milk fat yields. However, the 
ability of dietary fat supplementation 
to modulate digestion, metabolism and 
performance can be influenced by the 
type of fatty acid (chain length and degree 
of saturation). 
Our understanding of fat supplements 
is further complicated by the level 
of fatty acid enrichment, type of 
protection, physical form and size, 
degree of esterification, and magnitude 
of digestibility. To help unravel this 
complexity, the McFadden research group 
uses mass spectrometry-based lipidomics 
to biochemically map the bovine lipidome 
(over 1,400 complex lipids), resulting in 
the discovery of unique metabolic effects 
attributed to specific fatty acids. The 
current focus is on the role of ceramide 
during fat supplementation.
THE IMPORTANCE OF CERAMIDE
Ceramide is a type of sphingolipid 
found in tissues and circulation that is 
formed by saturated fatty acids, including 
palmitic acid and the nonessential amino 
acid serine (Figure 1). Similar to the 
diversity of fatty acids, ceramides vary 
in molecular structure and function. Our 
understanding of ceramide is primarily 
attributed to its role as an inducer 
of insulin resistance, fatty liver, and 
inflammation in diabetic non-ruminants 
that consume a caloric-rich diet 
enriched with palmitic acid. Albeit, these 
detrimental effects are highly-dependent 
on the degree of obesity, and whether 
ceramide accumulation becomes severe 
enough to develop into a homeostatic 
imbalance. This needs emphasis because 
in the absence of a metabolic disease, 
ceramide may also serve as an intrinsic 
control to partition nutrients towards 
fetal development and lactation. 
The potential ability of ceramide to 
decrease insulin sensitivity and enhance 
lactation performance in dairy cows are 
supported by several recent observations. 
• First, circulating, liver, and skeletal 
muscle ceramide concentrations increase 
in cows transitioning from pregnancy to 
lactation, but gradually decline beyond 
peak milk production. Interestingly, 
increases in circulating ceramide 
levels develop with adipose tissue 
breakdown, the systemic accumulation 
of nonesterifed fatty acids (NEFA) and 
suppressed insulin concentrations. 
• Second, ceramide blocks insulin-
stimulated glucose uptake in bovine 
adipocytes (fat cells) cultured with 
surplus energy. 
• Third, increasing circulating NEFA by 
intravenous triglyceride infusion or feed 
restriction increases ceramide and insulin 
intolerance. 
• Fourth, circulating ceramide is 
consistently positively related to milk 
yield in dairy cows. 
Thus, ceramide has emerged as a 
novel biomarker for nutrient partitioning 
in dairy cattle. With this in mind, how 
might nutritionists modify dietary fatty 
acid supply to 1) decrease ceramide 
synthesis in high-risk early lactation 
cows (cows with high body condition at 
calving) to potentially enhance insulin 
action, and lower circulating NEFA and 
liver lipid deposition or 2) increase 
ceramide synthesis to spare glucose 
for the mammary synthesis of milk in 
mid- or late-lactation dairy cows during 
positive energy balance? To explore 
these questions, investigative effort 
has focused on the metabolic effects of 
feeding highly-enriched palmitic acid 
supplements. 
PALMITIC ACID 
SUPPLEMENTATION INCREASES 
CERAMIDE SYNTHESIS
Palmitic acid is the preferred 
substrate of serine palmitoyltransferase 
within the de novo ceramide synthesis 
pathway (Figure 1). In addition, a second 
fatty acid is required by ceramide 
synthase, which is most often saturated, 
and either palmitic, behenic (C22:0), 
or lignoceric (C24:0) acid. Relative to a 
non-added fat control, feeding early and 
mid-lactation Holstein cows “high-palm” 
fats increases ceramide concentrations 
in blood and liver. Moreover, the ability 
of palmitic acid to increase circulating 
ceramide in mid-lactation cows remains 
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superior compared to stearic acid 
(C18:0) or medium-chain (C8:0 and 
C10:0) triglyceride supplementation. The 
increase in plasma ceramide levels due to 
palmitic acid supplementation appears to 
involve hepatic ceramide synthesis and 
the subsequent secretion of ceramide 
within very low density proteins. 
Indeed, palmitic acid feeding increases 
intracellular ceramide concentrations in 
bovine primary hepatocytes (liver cells) 
and circulating low-density lipoprotein 
ceramide concentrations increase in 
unison with hepatic NEFA uptake. 
Current data suggests palmitic acid 
feeding promotes nutrient partitioning 
via mechanisms involving ceramide. In 
support, circulating NEFA levels remain 
elevated following a glucose challenge 
in mid-lactation cows fed palmitic acid 
when compared with soyhull replacement. 
Circulating ceramide is positively related 
to the postpartum loss in adiposity and 
the adipose tissue activation of hormone-
sensitive lipase. Of potential concern, 
systemic ceramide concentrations are 
related to measures of inflammation, 
including adipose tissue macrophage 
trafficking and hepatic lipid accumulation 
during early lactation. However, plasma 
ceramide concentrations are consistently 
positively correlated with milk yield in 
lactating dairy cows that are clinically 
healthy. Collectively, these data suggest 
that a balance between health and milk 
production must be considered when 
feeding palmitic acid in early lactation 
cows at risk of developing metabolic 
disease. In herds challenged by poor 
postpartum health and reproductive 
performance, feeding highly-enriched 
palmitic acid supplements may be 
best reserved for beyond peak milk 
production. Such an approach holds the 
potential to enhance nutrient partitioning 
to favor milk synthesis without 
jeopardizing health. 
Current research is focused on the 
effects of dietary unsaturated fatty 
acid supplementation on ceramide 
synthesis. Albeit, our understanding and 
applications are complicated by their 
extensive rumen biohydrogenation. 
Nonetheless, early observations in lambs 
demonstrate that unprotected palmitoleic 
(C16:1) acid lowers ceramide supply. 
This is potentially of related importance 
because palmitoleic acid enhances insulin 
sensitivity in obese sheep. 
Because dairy cows fed diets 
containing polyunsaturated fatty acids 
(PUFA) have reduced pregnancy losses, 
and dietary PUFA decreases ceramide and 
increases insulin action in non-ruminants, 
we hypothesize that PUFA lowers 
ceramide levels and enhances insulin 
sensitivity in dairy cows. This possibility 
is currently being considered in lactating 
dairy cows at the Cornell University Dairy 
Research Center in Hartford, New York.
TAKE-HOME MESSAGE
Collectively, ceramide has emerged as 
a novel biomarker for insulin antagonism 
in dairy cattle and a target for the 
development of nutritional strategies 
aimed at modulating nutrient 
partitioning. Although studies have 
repeatedly demonstrated the ability 
of palm fat supplementation to induce 
ceramide synthesis in dairy cows, 
ongoing work aims to delineate the 
ceramide-related effects of very long-
chain saturated fatty acids and PUFA 
that escape biohydrogenation, and 
the influence of emulsifiers that may 
enhance palmitic acid digestibility. 
Moreover, we should consider how 
palmitic acid-induced ceramide 
accrual is influenced by dietary 
energy density, co-supplementation 
with other fatty acids, level of milk 
production, stage of lactation, and 
parity. Unraveling these uncertainties 
has the potential to optimize fatty acid 
nutrition in dairy cattle. ❚
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